Handelsbanken Fonder AB »

Dianthus Therapeutics shares owned by Handelsbanken Fonder AB

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Handelsbanken Fonder AB from 13F filings

Historical chart of Handelsbanken Fonder AB investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Handelsbanken Fonder AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Handelsbanken Fonder AB

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.5M 15k 97.45

More positions owned by Handelsbanken Fonder AB

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Alphabet Inc Class C cs (GOOG)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Micron Technology (MU)
Facebook Inc cl a (META)
Advanced Micro Devices (AMD)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Abbvie (ABBV)
Applied Materials (AMAT)

View all positions for Handelsbanken Fonder AB

Top funds holding Dianthus Therapeutics

FMR
BlackRock
RA Capital Management
Wellington Management Company
Fairmount Funds Management
Avidity Partners Management
Vanguard Capital Management
Octagon Capital Advisors
TCG Crossover Management
Citadel Advisors
State Street Corporation
VR Adviser
Fred Alger Management
Polar Capital Holdings
Deerfield Management Company

View all funds holding Dianthus Therapeutics